Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker SNDX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 2, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 2, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 4, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 14, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 10, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 10, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 10, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 10, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 10, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 4, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 4, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 4, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 4, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 30, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 12, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 19, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 3, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 24, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 4, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 26, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 16, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 16, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 5, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 5, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 3, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 3, 2025 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 20, 2024 | SNDX Syndax Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 18, 2024 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2024 | SNDX Syndax Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 5, 2024 | SNDX Syndax Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2024 | SNDX Syndax Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances